Jeannette Potts, Ph.D., J.D.

Chief Legal and Compliance Officer


Dr. Jeannette Potts joined uniQure as our Chief Legal and Compliance Officer in May 2023. Dr. Potts has more than 25 years of global legal, management and transactional experience in the biopharmaceutical industry. Most recently, she served as Senior Vice President, General Counsel & Corporate Secretary at Forma Therapeutics, a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancer, which was acquired by Novo Nordisk in 2022. There she designed, built and led the legal/IP/compliance team, held key roles in corporate financings and business development transactions, and was a trusted advisor to the executive team and Board of Directors on complex legal and business matters.

Prior to joining Forma, Dr. Potts served as Vice President, Legal and Head Counsel, Research and Development, at Takeda Pharmaceuticals, and had previously been Vice President, Legal at Millennium Pharmaceuticals before it was acquired by Takeda. She holds a bachelor’s degree in biology from Smith College, a Ph.D. in anatomy and cell biology from the University of Virginia, and a J.D. from Suffolk University.

uniQure Logo Twitter Icon LinkedIn Icon YouTube Icon Twitter Icon Arrow Slideshow Next Button